AOI, Hyderabad, gets Ethos, SGRT for cancer treatment


Rama Krishna Sangem

In a pioneering move in Telangana, American Oncology Institute (AOI), one of the largest cancer chain hospitals in South Asia, has successfully treated cervix and prostate cancer patients using Ethos and SGRT while solidifying its position as a leader in advanced cancer care solutions. AOI Hyderabad now provides patients access to state-of-the-art technology, leading to improved treatment outcomes and an elevated quality of life, said a press release.

Ethos an AI-driven holistic solution integrated with Varian’s most advanced surface guidance system, IDENTIFY™ technology, signifies a revolutionary advancement in precision cancer care. SGRT technology uses advanced 3D thermal camera technology, enabling real-time monitoring and tracking of patient positioning and motion during radiotherapy sessions, ensuring precise delivery of radiation to the tumor while minimizing exposure to surrounding healthy tissues.  .


Radiotherapy technology advanced

Dr Prabhakar P, Regional Chief Operating Officer (RCOO) of AOI, expressed his enthusiasm about this milestone, stating, “Radiotherapy technology has advanced quickly in recent years, the Indian radiotherapy market is projected to increase from $126 million in 2022 to $250 million in 2030, at a CAGR of 9 per cent. Using artificial intelligence (AI), advancements in radiotherapy can enhance accessibility and efficiency.

AI can improve treatment precision, minimize side effects, and optimize resource distribution through AI-driven treatment planning, precise dosage calculation, and real-time tumor tracking. We at AOI, are the first to combine both technologies to ensure best outcome and quality of life for the patients in Telangana. Integrating SGRT with Adaptive Ethos Radiotherapy represents a paradigm shift in cancer treatment.”

Dr Vinitha Reddy, Radiation Oncologist at AOI Hyderabad, highlighted the benefits of this integration for patients, saying, “The growing acceptance and recognition of Surface Guided Radiation Therapy (SGRT) as a promising imaging technique has supported its recent installation in a large number of radiation oncology facilities. The integration of SGRT and Ethos signifies a pioneering advancement in radiation therapy, epitomizing the future of precision treatment methods.

In terms of patient positioning, SGRT is an effective tool for the reduction of the overall treatment time and minimizing of imaging dose. It provides in-room online information of the complete surface and position of the patient. For superficial tumors, SGRT allows for a more accurate positioning compared to 3-point-lasers and might allow to reduce the number of daily imaging in some cases.


Rama Krishna Sangem

Ramakrishna chief editor of excel India online magazine and website

Leave a Reply

Your email address will not be published. Required fields are marked *

Next Post

Modi implements CAA. last of his poll planks in 2nd term

Tue Mar 12 , 2024
Rama Krishna Sangem Days before announcement of dates for the Lok Sabha (LS) elections by the Election Commission of India, the Centre on Tuesday notified […]
PM Modi

You May Like

Chief Editor

Rama Krishna Sangem

Excel India national news magazine is a media startup founded and piloted by Rama Krishna Sangem, a Hyderabad based senior journalist with over three decade experience in the field of media, mostly in print journalism. His rich experience in reporting for both Telugu and English newspapers and heading a TV news channel and some online outfits will be of immense use to this venture. Excel India English news magazine seeks to fill the gap of analytical understanding to our readers who today are confronted with myriad media platforms. Our online version not only offers regular updates and commentary on happenings around us, but also gives larger stories not limited by space constraints of a print magazine. Excel India is ably run by a team of senior journalists committed to values and quality standards in the profession. We urge you all to support and guide us in this endeavour. Reach us at